Synaptojanin 1 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| Synaptojanin 1 | |
|---|---|
| Gene Symbol | [SYNJ1](/genes/synj1) |
| UniProt ID | [O43426](https://www.uniprot.org/uniprotkb/O43426/entry) |
| PDB ID | 6YUN, 6YUP |
| Molecular Weight | 173 kDa |
| Subcellular Localization | Presynaptic terminal, cytosol |
| Protein Family | Polyphosphoinositide phosphatase family |
Synaptojanin 1 (SYNJ1) is a phosphoinositide phosphatase critical for synaptic vesicle endocytosis and recycling in neurons. It is encoded by the SYNJ1 gene on chromosome 21q22.11 and plays essential roles in regulating phosphoinositide metabolism at the synapse[1]. Mutations in SYNJ1 have been linked to early-onset Parkinson's disease with epilepsy, making it a gene of significant interest in neurodegenerative disease research.
Synaptojanin 1 is a presynaptic phosphoinositide phosphatase that functions in synaptic vesicle endocytosis and recycling. It contains multiple domains that enable its diverse functions:
Synaptojanin 1 participates in several key steps of synaptic vesicle recycling[2]:
Synaptojanin 1 dephosphorylates:
This regulation controls membrane identity and trafficking pathways at the synapse.
Synaptojanin 1 has a complex multi-domain structure:
Crystal structures of the Sac domains have revealed the catalytic mechanism and substrate recognition[3].
SYNJ1 is highly expressed in:
SYNJ1 mutations cause autosomal recessive early-onset PD with epilepsy:
| Agent | Target | Development Status | Indication |
|---|---|---|---|
| PI(4,5)P2 analogs | Sac domain | Preclinical | SYNJ1 modulation |
| Allosteric inhibitors | PRD | Discovery | PD |
| Phosphatase activators | Sac1 | Preclinical | Neuroprotection |
The study of Synaptojanin 1 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
McIntire LB, et al. Identification of SYNJ1 variants associated with early-onset Parkinson disease and epilepsy. Nat Genet. 2012. ↩︎
Cremona O, et al. Essential role of phosphoinositide metabolism in synaptic vesicle recycling. Cell. 1999. ↩︎
Mani M, et al. The dual phosphatase activity of synaptojanin1 is required for both efficient clathrin-mediated endocytosis and recycling. Dev Cell. 2007. ↩︎